These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity. Ryan DH Endocrine; 2000 Oct; 13(2):193-9. PubMed ID: 11186220 [TBL] [Abstract][Full Text] [Related]
29. Systematic review of the clinical efficacy of sibutramine and orlistat in weigth loss, quality of life and its adverse effects in obese adolescents. García Díaz E; Martín Folgueras T Nutr Hosp; 2011; 26(3):451-7. PubMed ID: 21892560 [TBL] [Abstract][Full Text] [Related]
30. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine]. Richter WO MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144 [TBL] [Abstract][Full Text] [Related]
31. The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort. Douglas IJ; Bhaskaran K; Batterham RL; Smeeth L Br J Clin Pharmacol; 2015 Jun; 79(6):1020-7. PubMed ID: 25641659 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review. Neovius M; Narbro K Int J Obes (Lond); 2008 Dec; 32(12):1752-63. PubMed ID: 18982009 [TBL] [Abstract][Full Text] [Related]
34. Rimonabant for the treatment of overweight and obese people. Burch J; McKenna C; Palmer S; Norman G; Glanville J; Sculpher M; Woolacott N Health Technol Assess; 2009 Oct; 13 Suppl 3():13-22. PubMed ID: 19846024 [TBL] [Abstract][Full Text] [Related]
36. [New drugs for the treatment of obesity]. Mustajoki P Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921 [No Abstract] [Full Text] [Related]
37. The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis. Sabuncu T; Nazligul Y; Karaoglanoglu M; Ucar E; Kilic FB Rom J Gastroenterol; 2003 Sep; 12(3):189-92. PubMed ID: 14502318 [TBL] [Abstract][Full Text] [Related]
38. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Glazer G Arch Intern Med; 2001 Aug 13-27; 161(15):1814-24. PubMed ID: 11493122 [TBL] [Abstract][Full Text] [Related]
40. Currently available drugs for the treatment of obesity: Sibutramine and orlistat. Chaput JP; St-Pierre S; Tremblay A Mini Rev Med Chem; 2007 Jan; 7(1):3-10. PubMed ID: 17266632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]